Hydrolases TRIZ Cases

RNase H2-dependent PCR primers resolve mismatch discrimination limits in CRISPR assays while reducing primer-dimer artifacts.

HO endonuclease mutation in S. eubayanus creates a heterothallic strain that overcomes low hybridization frequency and labor-intensive manual selection.

A polycistronic mRNA construct encodes multiple genome editing enzymes within a single nucleic acid sequence.

Collateral nuclease activity amplifies fluorescence signals to achieve attomolar sensitivity without complex instrumentation.

A 3D cell culturing system generates genome-edited keratinocytes using an extracellular matrix and growth factors.

Self-reporting transposons integrate into genomes and report locations via mRNA transcription.

Enzyme cascade treatment amplifies small structural differences between proteins, resolving mass spectrometry limitations that lose conformational information.

A peptide fragment derived from Porphyromonas gingivalis binds rheumatoid arthritis autoantibodies, resolving low sensitivity in traditional serological tests.

Measuring HLA-G, HLA-L, HLA-H, and HLA-J levels in tumor samples to predict patient response to cancer therapies.

Transgenic plants express a de-epoxidase enzyme that removes epoxy groups from vomitoxin, eliminating the need for external detoxification systems.

CRISPR/Cas9 system integrates reprogramming factors into the CASH-1 safe harbor site, reducing off-target mutagenesis and ensuring consistent expression.

Segmenting CRISPR guides into manageable pools resolves library complexity constraints while enabling accurate in vivo tumor progression tracking.

High-pressure homogenization enhances lipase catalytic efficiency during enzymatic hydrolysis of n-3 polyunsaturated fatty acids.

CRISPR-Cas9 targets the endogenous IL2RG locus in hematopoietic stem cells, reducing genotoxicity risks from random viral integration.

Silkworm silk glands secrete stable TRACP5b, overcoming low yields from unstable insect cell cultures.

Antibody-urease conjugates target CEACAM6-expressing cancer cells, raising local pH through urea hydrolysis while minimizing systemic toxicity.

Integrated heterologous target sequences enable one guide RNA to edit multiple loci simultaneously, reducing system complexity and component count.

Segmenting the type I-B Cas3 protein reduces molecular weight and eliminates off-target effects compared to class 2 systems.

Fusing chromatin-modulating peptides to base editors increases target accessibility, resolving low efficiency and high random indel frequencies.

Near-UV illumination unblocks photolabile adapters to capture targeted DNA sequences while preserving spatial context.

Engineered phytase variants with specific amino acid alterations improve enzyme thermostability and catalytic activity.

Hydrophobic solvent immobilization shields lipases from short-chain alcohols, resolving enzyme deactivation and enabling near-complete biodiesel conversion.

Modified guide RNAs direct CasPhi.12 to cleave mutant NRAS or KRAS alleles, resolving specificity trade-offs against wild-type sequences.

Genetic barcodes segment B cell populations to identify specific clones, resolving interference from polyclonal responses during vaccine development.

Targeted amino acid substitutions in a restriction enzyme variant increase cleavage selectivity for 5βghmC over 5 mC, reducing background digestion.

Optimized tissue culture conditions and chemical inhibitors block non-homologous end joining to increase homologous recombination efficiency in plants.

A dCas9-effector fusion protein regulates transcriptional activity in human embryonic stem cells to drive specific phenotypic changes.

Glucosyltransferase converts hmC to ghmC, enabling ZZYZ enzymes to discriminate modified bases and identify symmetric versus hemi-hydroxymethylated states.

Applying reagents to the shoot apical meristem of bridge transgenic plants enables direct in vivo editing, bypassing tissue culture regeneration bottlenecks.

CRISPR-Cas editing of LOX genes creates transgene-free maize, eliminating growth disruptions from traditional transgenic modifications.

CRISPR-Cas9 editing of viral and host genes reduces viral load while preventing drug resistance.

Synthetic polynucleotides with low soybean codon adaptation index increase RNA-guided nuclease expression in plant cells.

Combining gene repair oligonucleotides with DNA cutters improves genetic modification efficiency while reducing off-target effects.

Inactivating the B2M gene in B cells via CRISPR-Cas9 cleavage reduces host immune rejection during allogeneic transplantation.

A variant protease with specific amino acid substitutions enhances wash performance and stability in cleaning compositions.

Engineered phospholipase A1 maintains high activity across 40-70°C ranges, resolving stability limitations of conventional enzymes during oil degumming.

Targeted mutations at positions 251 and 204 resolve the trade-off between enzyme stability and activity, increasing hydrolytic efficiency.

Mutant Candida tropicalis strains overcome cytotoxic substrate inhibition to boost dicarboxylic acid yields in biological production.

Transposon systems engineer stem memory T cells to express specific surface markers, preventing cancer relapses through durable engraftment.

Specific amino acid substitutions in recombinase enzymes improve seeding efficiency and cluster amplification for PCR-free libraries on patterned flow cells.

Paired RNA-guided nickases create single-strand nicks to facilitate homologous recombination, reducing random mutations and screening time in polyploid crops.

Specific amino acid mutations in appA2C phytase variants maintain 50% activity at high temperatures, ensuring reliable phosphate release during feed pelleting.

CRISPR-mediated CD7 knockout prevents fratricide in CAR-T therapies by removing target antigens from healthy hematopoietic lineages.

Human-induced Lip1 gene mutations lower lipase activity, preventing lipid degradation and rancidity without costly post-harvest treatments.

A protein array platform detects anti-citrullinated protein antibodies in patient samples.

Nucleotide-modified messenger RNA encodes nucleases to initiate DNA double-strand breaks, resolving lung delivery barriers and immunogenicity risks.

A self-flocculating Pichia pastoris strain produces cordycepin and 3′-deoxyinosine with high titers.

Engineered E. coli fermentation replaces unsustainable plant extraction to produce high-purity 8-methyl nonanoic acid with improved yield and lower costs.

Site-directed mutagenesis of acid phosphatase boosts enzyme activity, resolving low productivity bottlenecks in nicotinamide riboside manufacturing.

Engineered bacteria overcome metabolic balance constraints by segmenting biosynthesis and degradation pathways, achieving near-theoretical fatty acid yields.